EVALUATION OF THERAPEUTIC POTENTIAL OF PTF1A ACTIVATION TO TREAT PANCREATIC CANCER USING A MICROFLUIDIC PANCREATIC ACINAR MODEL

Hye Ran Moon, Stephanie M. Venis, Yi Yang, Sagar M. Utturkar, Stephen F. Konieczny, Bumsoo Han

Research output: Chapter in Book/Report/Conference proceedingConference contribution

Abstract

Pancreatic cancer is an unmet clinical need, and effective therapeutic strategies are highly desired. This study aims to propose and evaluate a new therapeutic strategy based on the activation of the PTF1a gene in pancreatic cancer cells, using a microfluidic pancreatic cancer model. The underlying rationale is the loss of PTF1a in acinar cells drives the progression to pancreatic cancer. We first engineer pancreatic cancer cells, whose PTF1a activation is controllable, and then incorporate the cells into a microfluidic model mimicking acinar micro-anatomy. The model clearly shows that PTF1a activation can suppress the growth and invasion of cancer cells.

Original languageEnglish (US)
Title of host publicationMicroTAS 2021 - 25th International Conference on Miniaturized Systems for Chemistry and Life Sciences
PublisherChemical and Biological Microsystems Society
Pages1-2
Number of pages2
ISBN (Electronic)9781733419031
StatePublished - 2021
Externally publishedYes
Event25th International Conference on Miniaturized Systems for Chemistry and Life Sciences, MicroTAS 2021 - Palm Springs, Virtual, United States
Duration: Oct 10 2021Oct 14 2021

Publication series

NameMicroTAS 2021 - 25th International Conference on Miniaturized Systems for Chemistry and Life Sciences

Conference

Conference25th International Conference on Miniaturized Systems for Chemistry and Life Sciences, MicroTAS 2021
Country/TerritoryUnited States
CityPalm Springs, Virtual
Period10/10/2110/14/21

Keywords

  • microfluidic tissue model
  • pancreatic acinus
  • Pancreatic ductal adenocarcinoma
  • PTF1a

ASJC Scopus subject areas

  • Bioengineering
  • Chemical Engineering (miscellaneous)

Fingerprint

Dive into the research topics of 'EVALUATION OF THERAPEUTIC POTENTIAL OF PTF1A ACTIVATION TO TREAT PANCREATIC CANCER USING A MICROFLUIDIC PANCREATIC ACINAR MODEL'. Together they form a unique fingerprint.

Cite this